Interferon Alfa Therapy Based on Th17 Profile in Membranous Nephropathy
Condition: Membranous Nephropathy Intervention: Drug: Peginterferon Alfa-2A 180 MCG/ML Injectable Solution Sponsor: Centre Hospitalier Universitaire de Nice Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials